Benzinga | Aug 4, 2021 05:06PM EDT

Amedisys Q2 EPS $2.43 Beats $1.67 Estimate, Sales $564.20M Miss $566.19M Estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $2.43 per share which beat the analyst consensus estimate of $1.67 by 45.51 percent. This is a 81.34 percent increase over earnings of $1.34 per share from the same period last year. The company reported quarterly sales of $564.20 million which missed the analyst consensus estimate of $566.19 million by 0.35 percent. This is a 16.32 percent increase over sales of $485.06 million the same period last year.